Isavuconazole | List of Frontiers open access articles

Case Report

Published on 12 Jan 2026

Isavuconazole as initial antifungal therapy combined with surgical management of pediatric pulmonary mucormycosis: a case report and literature review

in Pediatric Infectious Diseases

Yao Sun
Lihua Yuan
Tianjiao Hu
Chuan Sun
Dandan Yang
Man Tian
Shichao Dong
Haiyan Gu

Frontiers in Pediatrics

doi 10.3389/fped.2025.1701905

1,131 views

Original Research

Published on 24 Feb 2025

Changes in the blood cyclosporine level after switching from voriconazole to isavuconazole in a patient with aplastic anemia: insights from physiologically based pharmacokinetic model simulation and the Adverse Event Reporting System database study

in Antimicrobials, Resistance and Chemotherapy

Chihiro Shiraishi
Hideo Kato
Kazuko Ino
Takuya Iwamoto

Frontiers in Microbiology

doi 10.3389/fmicb.2025.1525991

4,393 views
2 citations

Original Research

Published on 04 May 2023

Studies on the inhibitory effect of isavuconazole on flumatinib metabolism in vitro and in vivo

in Drug Metabolism and Transport

Ya-nan Liu
Xinhao Xu
Jingjing Nie
Yingying Hu
Xuegu Xu
Ren-ai Xu
Xiaoxiang Du

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1168852

4,128 views
7 citations

Case Report

Published on 12 Jan 2026

Isavuconazole in the treatment of acute invasive fungal sinusitis: two case reports and literature review

in Infectious Diseases: Pathogenesis and Therapy

Kun Zhao
Yuwan Song
Huhuifen He
Fengxin Yang
He Zhao
Yan Wang
Li Wang
Yan Wang
Yan Sun

Frontiers in Medicine

doi 10.3389/fmed.2025.1700685

1,144 views
2 citations

Case Report

Published on 23 Mar 2026

Case Report: Pediatric isavuconazole supratherapeutic exposure: a case of long-term use, CYP3A5 poor metabolizer genotype and concomitant CYP3A4 medications

in Obstetric and Pediatric Pharmacology

Manman Liu
Lan Li
Chen Zhou
Changying Luo
Xiaodong Wang
Juan Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2026.1807350

426 views

Case Report

Published on 11 Jun 2019

Hepatotoxicity Due to Azole Antimycotic Agents in a HLA B*35:02-Positive Patient

in Predictive Toxicology

Tim Bühler
Michael Medinger
Jamal Bouitbir
Stephan Krähenbühl
Anne Leuppi-Taegtmeyer

Frontiers in Pharmacology

doi 10.3389/fphar.2019.00645

11,846 views
11 citations

Review

Published on 25 Sep 2023

Virulence traits and novel drug delivery strategies for mucormycosis post-COVID-19: a comprehensive review

in Microbial Immunology

Md. Faiyazuddin
A. Sophia
Sumel Ashique
Amol D. Gholap
S. Gowri
Sourav Mohanto
C. Karthikeyan
Sagnik Nag
Arif Hussain
Mohammad Shabib Akhtar

Frontiers in Immunology

doi 10.3389/fimmu.2023.1264502

12,914 views
17 citations

Case Report

Published on 25 Feb 2022

How to Treat a Child With a Concurrent Diagnosis of Leukemia and Generalized Mucormycosis? Case Report

in Infectious Diseases: Pathogenesis and Therapy

Patrycja Sosnowska-Sienkiewicz
Kinga Błaszczyk
Honorata Kubisiak-Rzepczyk
Przemysław Mańkowski
Danuta Januszkiewicz-Lewandowska

Frontiers in Medicine

doi 10.3389/fmed.2022.844880

3,243 views
9 citations

Original Research

Published on 29 Nov 2021

The Effect of Posaconazole and Isavuconazole on the Pharmacokinetics of Erdafitinib in Beagle Dogs by UPLC-MS/MS

in Drug Metabolism and Transport

Lan-hong Ruan
Ling-ling Fan
Kun Wang
Wan-qi Zhang
Xiao-jun Wang
Xiang-jun Qiu

Frontiers in Pharmacology

doi 10.3389/fphar.2021.749169

4,471 views
11 citations

Original Research

Published on 07 Jan 2026

Pharmacovigilance insights: safety profiles of antifungal agents for invasive aspergillosis

in Pharmacoepidemiology

Wei Jia
Tiezhou Wang
Jingru Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1718019

1,267 views

Original Research

Published on 23 Jan 2025

A post-marketing pharmacovigilance study of triazole antifungals: adverse event data mining and analysis based on the FDA adverse event reporting system database

in Pharmacoepidemiology

Yalan Tian
Min Jin
Hong Ning

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1462510

3,914 views
3 citations

Original Research

Accepted on 04 May 2026

Comparative risk of arrhythmias associated with systemic antifungal agents: A disproportionality analysis of the FAERS database

in Pharmacoepidemiology

Xiaohu Yang
Hao Li
Kai Liu
Lingti Kong

Frontiers in Pharmacology

167 views

Case Report

Accepted on 30 Apr 2026

Invasive Cunninghamella bertholletiae Infections in Pediatrics: A case series and literature review

in Pediatric Infectious Diseases

Xue Li
Kunjiao Xue
Jiakai Li
Tingting Zhang
Xiaoxi Lu
Chuanjie Yuan
Jin wu
Xiangfei Zeng
Min Shu
Juanjuan Lyu

Frontiers in Pediatrics

128 views

Brief Research Report

Published on 28 Jul 2025

A breakthrough Trichosporon asahii infection in an immune thrombocytopenia patient during caspofungin and isavuconazole combined therapy: a case report

in Clinical Infectious Diseases

Yan Lu
Yanting Sun
Yankun Li
Yingjie Wang
Dawei Wu
Zhi Li
Xi Guo

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2025.1625007

2,774 views
1 citation

Case Report

Published on 24 Jun 2024

Case report: Successful combination therapy with isavuconazole and amphotericin B in treatment of disseminated Candida tropicalis infection

in Infectious Diseases: Pathogenesis and Therapy

Qibei Teng
Xueshi Ye
Bei Wang
Xinyue Zhang
Zhizhi Tao
Xiufeng Yin
Qianqian Yang

Frontiers in Medicine

doi 10.3389/fmed.2024.1397539

3,128 views
6 citations

Original Research

Published on 19 Dec 2023

Pharmacoeconomic evaluation of isavuconazole, posaconazole, and voriconazole for the treatment of invasive mold diseases in hematological patients: initial therapy prior to pathogen differential diagnosis in China

in Health Economics

Guangxin Han
Qing Xu
Qianzhou Lv
Xiaoyu Li
Xiaoping Shi

Frontiers in Public Health

doi 10.3389/fpubh.2023.1292162

4,197 views
8 citations

Articles

Isavuconazole as initial antifungal therapy combined with surgical management of pediatric pulmonary mucormycosis: a case report and literature review

Changes in the blood cyclosporine level after switching from voriconazole to isavuconazole in a patient with aplastic anemia: insights from physiologically based pharmacokinetic model simulation and the Adverse Event Reporting System database study

Studies on the inhibitory effect of isavuconazole on flumatinib metabolism in vitro and in vivo

Isavuconazole in the treatment of acute invasive fungal sinusitis: two case reports and literature review

Case Report: Pediatric isavuconazole supratherapeutic exposure: a case of long-term use, CYP3A5 poor metabolizer genotype and concomitant CYP3A4 medications

Hepatotoxicity Due to Azole Antimycotic Agents in a HLA B*35:02-Positive Patient

Virulence traits and novel drug delivery strategies for mucormycosis post-COVID-19: a comprehensive review

How to Treat a Child With a Concurrent Diagnosis of Leukemia and Generalized Mucormycosis? Case Report

The Effect of Posaconazole and Isavuconazole on the Pharmacokinetics of Erdafitinib in Beagle Dogs by UPLC-MS/MS

Pharmacovigilance insights: safety profiles of antifungal agents for invasive aspergillosis

A post-marketing pharmacovigilance study of triazole antifungals: adverse event data mining and analysis based on the FDA adverse event reporting system database

Comparative risk of arrhythmias associated with systemic antifungal agents: A disproportionality analysis of the FAERS database

Invasive Cunninghamella bertholletiae Infections in Pediatrics: A case series and literature review

A breakthrough Trichosporon asahii infection in an immune thrombocytopenia patient during caspofungin and isavuconazole combined therapy: a case report

Case report: Successful combination therapy with isavuconazole and amphotericin B in treatment of disseminated Candida tropicalis infection

Pharmacoeconomic evaluation of isavuconazole, posaconazole, and voriconazole for the treatment of invasive mold diseases in hematological patients: initial therapy prior to pathogen differential diagnosis in China